Usuda Katsuo, Iwai Shun, Yamagata Aika, Sekimura Atsushi, Motono Nozomu, Matoba Munetaka, Doai Mariko, Yamada Sohsuke, Ueda Yoshimichi, Hirata Keiya, Uramoto Hidetaka
Department of Thoracic Surgery, Kanazawa Medical University, Ishikawa 920-0293, Japan.
Department of Radiology, Kanazawa Medical University, Ishikawa 920-0293, Japan.
Cancers (Basel). 2020 May 8;12(5):1194. doi: 10.3390/cancers12051194.
For detecting malignant tumors, diffusion-weighted magnetic resonance imaging (DWI) as well as fluoro-2-deoxy-glucose positron emission tomography/computed tomography (FDG-PET/CT) are available. It is not definitive how DWI correlates the pathological findings of lung cancer. The aim of this study is to evaluate the relationships between DWI findings and pathologic findings. In this study, 226 patients with resected lung cancers were enrolled. DWI was performed on each patient before surgery. There were 167 patients with adenocarcinoma, 44 patients with squamous cell carcinoma, and 15 patients with other cell types. Relationships between the apparent diffusion coefficient (ADC) of DWI and the pathology were analyzed. When the optimal cutoff value (OCV) of ADC for diagnosing malignancy was 1.70 × 10 mm/s, the sensitivity of DWI was 92.0% (208/226). The sensitivity was 33.3% (3/9) in mucinous adenocarcinoma. The ADC value (1.31 ± 0.32 × 10 mm/s) of adenocarcinoma was significantly higher than that (1.17 ± 0.29 × 10 mm/s) of squamous cell carcinoma ( = 0.012), or (0.93 ± 0.14 × 10 mm/s) of small cell carcinoma ( = 0.0095). The ADC value (1.91 ± 0.36 × 10 mm/s) of mucinous adenocarcinoma was significantly higher than that (1.25 ± 0.25 × 10 mm/s) of adenocarcinoma with mucin and that (1.24 ± 0.30 × 10 mm/s) of other cell types. The ADC (1.11 ± 0.26 × 10 mm/s) of lung cancer with necrosis was significantly lower than that (1.32 ± 0.33 × 10 mm/s) of lung cancer without necrosis. The ADC of mucinous adenocarcinoma was significantly higher than those of adenocarcinoma of other cell types. The ADC of lung cancer was likely to decrease according to cell differentiation decreasing. The sensitivity of DWI for lung cancer was 92% and this result shows that DWI is valuable for the evaluation of lung cancer. Lung cancer could be evaluated qualitatively using DWI.
对于检测恶性肿瘤,可采用扩散加权磁共振成像(DWI)以及氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)。DWI与肺癌病理结果之间的相关性尚无定论。本研究旨在评估DWI表现与病理结果之间的关系。本研究纳入了226例接受肺癌切除术的患者。术前对每位患者进行了DWI检查。其中腺癌患者167例,鳞状细胞癌患者44例,其他细胞类型患者15例。分析了DWI的表观扩散系数(ADC)与病理之间的关系。当诊断恶性肿瘤的ADC最佳截断值(OCV)为1.70×10⁻³mm²/s时,DWI的敏感性为92.0%(208/226)。黏液腺癌的敏感性为33.3%(3/9)。腺癌的ADC值(1.31±0.32×10⁻³mm²/s)显著高于鳞状细胞癌的ADC值(1.17±0.29×10⁻³mm²/s)(P = 0.012),或高于小细胞癌的ADC值(0.93±0.14×10⁻³mm²/s)(P = 0.0095)。黏液腺癌的ADC值(1.91±0.36×10⁻³mm²/s)显著高于伴有黏液的腺癌的ADC值(1.25±0.25×10⁻³mm²/s)以及其他细胞类型的ADC值(1.24±0.30×10⁻³mm²/s)。伴有坏死的肺癌的ADC值(1.11±0.26×10⁻³mm²/s)显著低于无坏死的肺癌的ADC值(1.32±0.33×10⁻³mm²/s)。黏液腺癌的ADC值显著高于其他细胞类型的腺癌。肺癌的ADC值可能会随着细胞分化程度的降低而降低。DWI对肺癌的敏感性为92%,这一结果表明DWI对肺癌评估具有重要价值。可使用DWI对肺癌进行定性评估。